Press Releases
August 4, 2026
Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
July 30, 2026
Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
Upcoming Events
Past Events
30Jul
2026
Second quarter 2026 results
Second quarter 2026 results were reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation was followed by a Q&A session.
Quarterly results
23Apr
2026
First quarter 2026 results
Q1 2026 results were reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation was followed by a Q&A session.
Quarterly results
29Jan
2026
Fourth quarter & full year 2025 results
Fourth quarter and full year 2025 results were reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation was followed by a Q&A session.
Quarterly results